{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:29:20Z","timestamp":1786350560184,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNNR-MCNT1-2023- 12378408"],"award-info":[{"award-number":["PNNR-MCNT1-2023- 12378408"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00415-026-14022-6","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:05:52Z","timestamp":1784721952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of continuous subcutaneous foslevodopa\/foscarbidopa infusion on gait in advanced Parkinson\u2019s disease: a real-world wearable-based study"],"prefix":"10.1007","volume":"273","author":[{"given":"Kristi","family":"Meksi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Simonetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Campone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Avvento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Pierantozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"7","key":"14022_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","volume":"18","author":"A Mirelman","year":"2019","unstructured":"Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL et al (2019) Gait impairments in Parkinson\u2019s disease. Lancet Neurol 18(7):697\u2013708","journal-title":"Lancet Neurol"},{"issue":"15","key":"14022_CR2","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/mds.21659","volume":"22","author":"O Moore","year":"2007","unstructured":"Moore O, Peretz C, Giladi N (2007) Freezing of gait affects quality of life of peoples with Parkinson\u2019s disease beyond its relationships with mobility and gait. Mov Disord 22(15):2192\u20132195","journal-title":"Mov Disord"},{"key":"14022_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-025-01179-3","author":"M Gilat","year":"2026","unstructured":"Gilat M, Nonnekes J, Factor SA et al (2026) An updated definition of freezing of gait. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/s41582-025-01179-3","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"14022_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.26082","volume":"30","author":"PA LeWitt","year":"2015","unstructured":"LeWitt PA (2015) Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics. Mov Disord 30(1):64\u201372","journal-title":"Mov Disord"},{"key":"14022_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2016.07.006","volume":"31","author":"K Smulders","year":"2016","unstructured":"Smulders K, Dale ML, Carlson-Kuhta P, Nutt JG, Horak FB (2016) Pharmacological treatment in Parkinson\u2019s disease: effects on gait. Parkinsonism Relat Disord 31:3\u201313","journal-title":"Parkinsonism Relat Disord"},{"key":"14022_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2025.108848","volume":"252","author":"S Alshimemeri","year":"2025","unstructured":"Alshimemeri S, Alhayssoni A, Hazazi R (2025) Clinical predictors of freezing of gait in patients with Parkinson\u2019s disease: a systematic review. Clin Neurol Neurosurg 252:108848","journal-title":"Clin Neurol Neurosurg"},{"key":"14022_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.912343","volume":"13","author":"D Rodr\u00edguez-Mart\u00edn","year":"2022","unstructured":"Rodr\u00edguez-Mart\u00edn D, Cabestany J, P\u00e9rez-L\u00f3pez C, Pie M, Calvet J, Sam\u00e0 A et al (2022) A new paradigm in Parkinson\u2019s disease evaluation with wearable medical devices: a review of STAT-ONTM. Front Neurol 13:912343","journal-title":"Front Neurol"},{"issue":"16","key":"14022_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/s25164889","volume":"25","author":"G Farabolini","year":"2025","unstructured":"Farabolini G, Baldini N, Pagano A, Andrenelli E, Pepa L, Morone G et al (2025) Continuous movement monitoring at home through wearable devices: a systematic review. Sensors (Basel) 25(16):4889","journal-title":"Sensors (Basel)"},{"issue":"2","key":"14022_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","volume":"13","author":"CW Olanow","year":"2014","unstructured":"Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH et al (2014) Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson\u2019s disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 13(2):141\u2013149","journal-title":"Lancet Neurol"},{"key":"14022_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2017.09.018","volume":"45","author":"A Antonini","year":"2017","unstructured":"Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirto\u0161ek Z et al (2017) Levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s: final results of the GLORIA registry. Parkinsonism Relat Disord 45:13\u201320","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"14022_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3233\/JPD-240003","volume":"14","author":"G Imbalzano","year":"2024","unstructured":"Imbalzano G, Artusi CA, Ledda C, Montanaro E, Romagnolo A, Rizzone MG et al (2024) Effects of continuous dopaminergic stimulation on Parkinson\u2019s disease gait: a longitudinal prospective study with levodopa intestinal gel infusion. J Parkinsons Dis 14(4):843\u2013853","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"14022_CR12","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3233\/JPD-212813","volume":"11","author":"M Rosebraugh","year":"2021","unstructured":"Rosebraugh M, Liu W, Neenan M, Facheris MF (2021) Foslevodopa\/foscarbidopa is well tolerated and maintains stable levodopa and carbidopa exposure following subcutaneous infusion. JPD 11(4):1695\u20131702","journal-title":"JPD"},{"issue":"5","key":"14022_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(24)00052-8","volume":"23","author":"AJ Espay","year":"2024","unstructured":"Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ et al (2024) Safety and efficacy of continuous subcutaneous levodopa\u2013carbidopa infusion (ND0612) for Parkinson\u2019s disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial. Lancet Neurol 23(5):465\u2013476","journal-title":"Lancet Neurol"},{"issue":"12","key":"14022_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"15","key":"14022_CR15","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25(15):2649\u20132653","journal-title":"Mov Disord"},{"issue":"1","key":"14022_CR16","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.2196\/rehab.8335","volume":"5","author":"A Rodr\u00edguez-Molinero","year":"2018","unstructured":"Rodr\u00edguez-Molinero A, P\u00e9rez-L\u00f3pez C, Sam\u00e0 A, De Mingo E, Rodr\u00edguez-Mart\u00edn D, Hern\u00e1ndez-Vara J et al (2018) A kinematic sensor and algorithm to detect motor fluctuations in Parkinson disease: validation study under real conditions of use. JMIR Rehabil Assist Technol 5(1):e8","journal-title":"JMIR Rehabil Assist Technol"},{"issue":"2","key":"14022_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171764","volume":"12","author":"D Rodr\u00edguez-Mart\u00edn","year":"2017","unstructured":"Rodr\u00edguez-Mart\u00edn D, Sam\u00e0 A, P\u00e9rez-L\u00f3pez C, Catal\u00e0 A, Moreno Arostegui JM, Cabestany J et al (2017) Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer. PLoS ONE 12(2):e0171764","journal-title":"PLoS ONE"},{"key":"14022_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2022.100148","volume":"7","author":"MR Shackleford","year":"2022","unstructured":"Shackleford MR, Mishra V, Mari Z (2022) Levodopa-Carbidopa Intestinal Gel may improve treatment-resistant freezing of gait in Parkinson\u2019s disease. Clin Parkinsonism & Relat Disord 7:100148","journal-title":"Clin Parkinsonism & Relat Disord"},{"issue":"2","key":"14022_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/ane.13110","volume":"140","author":"M Fabbri","year":"2019","unstructured":"Fabbri M, Pongmala C, Artusi CA, Romagnolo A, Rizzone MG, Zibetti M et al (2019) Long\u2010term effect of levodopa\u2010carbidopa intestinal gel on axial signs in Parkinson\u2019s disease. Acta Neurol Scand 140(2):157\u2013161","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"14022_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/mdc3.12640","volume":"5","author":"V Rispoli","year":"2018","unstructured":"Rispoli V, Golfr\u00e8 Andreasi N, Penna G, Preda F, Contini E, Sensi M (2018) Levodopa\/Carbidopa intestinal gel infusion therapy: focus on gait and balance. Mov Disord Clin Pract 5(5):542\u2013545","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"14022_CR21","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/mds.25683","volume":"28","author":"A Nieuwboer","year":"2013","unstructured":"Nieuwboer A, Giladi N (2013) Characterizing freezing of gait in Parkinson\u2019s disease: models of an episodic phenomenon. Mov Disord 28(11):1509\u20131519","journal-title":"Mov Disord"},{"issue":"3","key":"14022_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2019.4006","volume":"77","author":"J Nonnekes","year":"2020","unstructured":"Nonnekes J, Bereau M, Bloem BR (2020) Freezing of gait and its levodopa paradox. JAMA Neurol 77(3):287","journal-title":"JAMA Neurol"},{"issue":"3","key":"14022_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.parkreldis.2014.12.019","volume":"21","author":"FCF Chang","year":"2015","unstructured":"Chang FCF, Tsui DS, Mahant N, Wolfe N, Kim SD, Ha AD et al (2015) 24 h Levodopa\u2013carbidopa intestinal gel may reduce falls and \u201cunresponsive\u201d freezing of gait in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(3):317\u2013320","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"14022_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/NRE-2011-0700","volume":"29","author":"MS Bryant","year":"2011","unstructured":"Bryant MS, Rintala DH, Hou JG, Lai EC, Protas EJ (2011) Effects of levodopa on forward and backward gait patterns in persons with Parkinson\u2019s disease. NeuroRehabilitation 29(3):247\u2013252","journal-title":"NeuroRehabilitation"},{"issue":"12","key":"14022_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","volume":"21","author":"MJ Soileau","year":"2022","unstructured":"Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A et al (2022) Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson\u2019s disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol 21(12):1099\u20131109","journal-title":"Lancet Neurol"},{"issue":"6","key":"14022_CR26","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s40120-023-00533-1","volume":"12","author":"J Aldred","year":"2023","unstructured":"Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F et al (2023) Continuous subcutaneous foslevodopa\/foscarbidopa in Parkinson\u2019s disease: safety and efficacy results from a 12-month, single-arm, open-label, phase 3 study. Neurol Ther 12(6):1937\u20131958","journal-title":"Neurol Ther"},{"issue":"4","key":"14022_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1468-1331.2003.00611.x","volume":"10","author":"JD Schaafsma","year":"2003","unstructured":"Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N (2003) Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson\u2019s disease. Eur J Neurol 10(4):391\u2013398","journal-title":"Eur J Neurol"},{"key":"14022_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jns.2017.12.012","volume":"385","author":"M Zibetti","year":"2018","unstructured":"Zibetti M, Angrisano S, Dematteis F, Artusi CA, Romagnolo A, Merola A et al (2018) Effects of intestinal levodopa infusion on freezing of gait in Parkinson disease. J Neurol Sci 385:105\u2013108","journal-title":"J Neurol Sci"},{"issue":"9","key":"14022_CR29","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10072-015-2234-x","volume":"36","author":"G Cossu","year":"2015","unstructured":"Cossu G, Ricchi V, Pilleri M, Mancini F, Murgia D, Ricchieri G et al (2015) Levodopa\u2013carbidopa intrajejunal gel in advanced Parkinson disease with \u201con\u201d freezing of gait. Neurol Sci 36(9):1683\u20131686","journal-title":"Neurol Sci"},{"issue":"6","key":"14022_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269227","volume":"17","author":"RD Landes","year":"2022","unstructured":"Landes RD, Glover A, Pillai L, Doerhoff S, Virmani T (2022) Levodopa ONOFF-state freezing of gait: defining the gait and non-motor phenotype. PLoS ONE 17(6):e0269227","journal-title":"PLoS ONE"},{"issue":"7","key":"14022_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1212\/WNL.0b013e3182477ec0","volume":"78","author":"AJ Espay","year":"2012","unstructured":"Espay AJ, Fasano A, Van Nuenen BFL, Payne MM, Snijders AH, Bloem BR (2012) \u201cOn\u201d state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology 78(7):454\u2013457","journal-title":"Neurology"},{"issue":"5","key":"14022_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/mds.27671","volume":"34","author":"AJ Espay","year":"2019","unstructured":"Espay AJ, Hausdorff JM, S\u00e1nchez\u2010Ferro \u00c1, Klucken J, Merola A, Bonato P et al (2019) A roadmap for implementation of patient\u2010centered digital outcome measures in Parkinson\u2019s disease obtained using mobile health technologies. Mov Disord 34(5):657\u2013663","journal-title":"Mov Disord"},{"issue":"6","key":"14022_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13123-y","volume":"272","author":"M Soileau","year":"2025","unstructured":"Soileau M, Kumar R, Parab A, Brion T, White K, Yan CH et al (2025) Patients\u2019 experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa\/foscarbidopa in Parkinson\u2019s disease. J Neurol 272(6):416","journal-title":"J Neurol"},{"issue":"16","key":"14022_CR34","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.3390\/s25165101","volume":"25","author":"M Gregor\u010di\u010d","year":"2025","unstructured":"Gregor\u010di\u010d M, Georgiev D (2025) The usefulness of wearable sensors for detecting freezing of gait in Parkinson\u2019s disease: a systematic review. Sensors (Basel) 25(16):5101. https:\/\/doi.org\/10.3390\/s25165101. (PMID:40871963;PMCID:PMC12389820)","journal-title":"Sensors (Basel)"},{"issue":"3","key":"14022_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.70424","volume":"63","author":"A Salomon","year":"2026","unstructured":"Salomon A, Gazit E, Shimoni N et al (2026) Beyond the leaderboard: evaluating the robustness of deep learning models for detecting freezing of gait. Eur J Neurosci 63(3):e70424. https:\/\/doi.org\/10.1111\/ejn.70424","journal-title":"Eur J Neurosci"},{"key":"14022_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/mdc3.12893","volume":"7","author":"F Hulzinga","year":"2020","unstructured":"Hulzinga F, Nieuwboer A, Dijkstra BW, Mancini M, Strouwen C, Bloem BR, Ginis P (2020) The new freezing of gait questionnaire: unsuitable as an outcome in clinical trials? Mov Disord Clin Pract 7:199\u2013205. https:\/\/doi.org\/10.1002\/mdc3.12893","journal-title":"Mov Disord Clin Pract"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14022-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:49:45Z","timestamp":1786348185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-14022-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["14022"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14022-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"481"}}